Showing results (41-50 of 205) with videos related to

Sort By:
Pageof 21
Frontiers in Cell and Developmental Biology|July 21, 2022
Why is Mortalin a Potential Therapeutic Target for Cancer?A-Rum Yoon, Renu Wadhwa, Sunil C Kaul, et al.
Plos One|October 27, 2010
Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signalingNashi Widodo, Didik Priyandoko, Navjot Shah, et al.
Experimental Gerontology|December 10, 2002
Mortalin: present and prospectiveSunil C Kaul, Kazunari Taira, Olivia M Pereira-Smith, et al.
Neurochemistry International|July 10, 2021
Experimental evidence and mechanism of action of some popular neuro-nutraceutical herbsAshish Kumar, Arpita Konar, Sukant Garg, et al.
Biotechniques|September 11, 2019
Express ELISA for detection of mortalinSukant Garg, Chun Wu, Yoshihiro Ohmiya, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|April 22, 2014
Targeting of DNA Damage Signaling Pathway Induced Senescence and Reduced Migration of Cancer cellsRan Gao, Rumani Singh, Zeenia Kaul, et al.
Biomolecules|February 25, 2022
Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and WithanoneVidhi Malik, Navaneethan Radhakrishnan, Sunil C Kaul, et al.
Current Pharmaceutical Design|August 28, 2012
Druggability of mortalin for cancer and neuro-degenerative disordersCuster C Deocaris, Wen-Jing Lu, Sunil C Kaul, et al.
Biomolecules|February 3, 2021
Computational Insights into the Potential of Withaferin-A, Withanone and Caffeic Acid Phenethyl Ester for Treatment of Aberrant-EGFR Driven Lung CancersVidhi Malik, Vipul Kumar, Sunil C Kaul, et al.
Chemistry, an Asian Journal|July 7, 2009
Improvement of targeted gene delivery to human cancer cells by a novel trifunctional crosslinkerMaki Shiota, Lahman Shamsur, Shun-ichi Kawahara, et al.
Pageof 21